Tenax Therapeutics (TENX) Accumulated Depreciation (2015 - 2021)

Tenax Therapeutics (TENX) has 5 years of Accumulated Depreciation data on file, last reported at $60843.0 in Q2 2021.

• For the quarter ending Q2 2021, Accumulated Depreciation changed 0.1% year-over-year to $60843.0; the trailing twelve-month figure through Jun 2021 stood at $60843.0 (changed 0.1% YoY), and the FY2020 full-year result was $60368.0, down 70.45% from the prior year.
• Accumulated Depreciation climbed to $60843.0 in Q2 2021, from $59953.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $573121.0 in Q4 2018 to a low of $59389.0 in Q3 2020.
• A 4-year average of $161658.2 and a median of $74785.0 in 2020 frame the typical range for Accumulated Depreciation.
• Across the five-year window, Accumulated Depreciation sank 70.74% in 2020 and decreased 0.1% in 2021, its largest moves.
• Tracing TENX's Accumulated Depreciation over 4 years: stood at $573121.0 in 2018, then plunged by 64.35% to $204302.0 in 2019, then sank by 70.45% to $60368.0 in 2020, then gained by 0.79% to $60843.0 in 2021.
• Business Quant data shows TENX's Accumulated Depreciation at $60843.0 in Q2 2021, $59953.0 in Q1 2021, and $60368.0 in Q4 2020.